MAZE EPS Estimates
Maze Therapeutics, Inc.
$27.50
+$1.27(+4.84%)
58
Overall
60
Value
72
Tech
44
Quality
Market Cap
$1.46B
Volume
47.66K
52W Range
$21.95 - $53.65
Target Price
$61.50
MAZE EPS estimates: the consensus estimate for Maze Therapeutics, Inc.'s current fiscal year is -$2.70 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
MAZE EPS Estimates
- EPS estimate, current quarter
- $-0.78
- EPS estimate, next quarter
- $-0.80
- EPS estimate, current year
- $-2.70
- EPS estimate, next year
- $-3.15
- EPS growth, 3-year
- +73.64%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.05 |
| 2024 | $1.42 |
| 2023 | $-43.89 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MAZE | $27.50 | +4.8% | 47.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |